Atorvastatin 40mg: Clinical Trials

6 trials of Atorvastatin 40mg, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 recruiting, 1 completed, 1 withdrawn. 6 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 26Recruiting 4, Completed 1, Withdrawn 1
Phase 11Withdrawn 1
Phase 31Recruiting 1

Follow Atorvastatin 40mg: new trials by email Literature Review of Atorvastatin 40mg trials Research Report on Atorvastatin 40mg

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prophylactic Treatment With Atorvastatin for Chronic Migraine (ChronicStatinMig)
Atorvastatin 40mg, Placebo - Chronic Migraine
Phase 2RecruitingSt. Olavs Hospital3002024-05-012026-07-20
Prophylactic Treatment With Atorvastatin for Episodic Migraine.
Atorvastatin 40mg, Placebo, Atorvastatin 20mg - Episodic Migraine
Phase 2RecruitingSt. Olavs Hospital4502024-05-012026-07-14
ATORvastatin in Pulmonary TUBerculosis
Atorvastatin 20mg, Atorvastatin 40mg, Atorvastatin 60mg - Pulmonary Tuberculosis, Tuberculosis
Phase 2RecruitingObafemi Awolowo University Teaching Hospital4402024-01-032025-09-25
Comparison Between the Effects of High Doses Statin on Ventricular Remodeling in STEMI Patients
Rosuvastatin 20 mg, Atorvastatin 40mg - ST-segment Elevation Myocardial Infarction
Phase 2CompletedDamanhour University802021-11-012024-08-01
Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion
Atorvastatin 40mg, Placebo oral tablet - Tuberculosis, Pulmonary
Phase 2 / Phase 3RecruitingUniversity of Cape Town2202020-07-142024-08-23
High-intensity Atorvastatin for Arteriovenous Fistula Failure (HAFF): A Feasibility Pilot Study
Atorvastatin 40mg, Placebo - Primary Arteriovenous Fistula Failure
Phase 1 / Phase 2WithdrawnAlbany Medical College2018-11-012020-01-18

Conditions studied

Migraine Disorders (2)  ·  Tuberculosis (2)  ·  Tuberculosis, Pulmonary (2)  ·  Inflammation (1)  ·  Pulmonary Disease, Chronic Obstructive (1)  ·  ST Elevation Myocardial Infarction (1)

Sponsors

St. Olavs Hospital (2)  ·  Albany Medical College (1)  ·  Damanhour University (1)  ·  Obafemi Awolowo University Teaching Hospital (1)  ·  University of Cape Town (1)

Countries

Norway (2)  ·  Egypt (1)  ·  Nigeria (1)  ·  South Africa (1)  ·  United States (1)

Top investigators

Linn H Steffensen, Associate Professor II (2)  ·  Amira B Kassem, PhD (1)  ·  Anne H Aamodt, Senior researcher (1)  ·  Anne H. Aamodt, Senior researcher (1)  ·  Bendik S Winsvold, Post.doc. (1)  ·  Bendik S. Winswold, Post.doc. (1)  ·  Bolanle A Omotoso, MD (1)  ·  Friedrich Thienemann, MD (1)  ·  Kjersti G Vetvik, Ph.d. (1)  ·  Kjersti G. Vetvik, Ph.d. (1)  ·  Loay Salman, MD,MBA (1)  ·  Olanisun O Adewole, MD (1)

Results publications

PMID 39264503